HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Burney Co.

Burney Co. reduced its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 35,325 shares of the company’s stock after selling 793 shares during the period. Burney Co.’s holdings in HCA Healthcare were worth $10,603,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Benjamin F. Edwards & Company Inc. purchased a new position in HCA Healthcare in the second quarter valued at $33,000. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare during the third quarter worth approximately $39,000. Canoe Financial LP acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $41,000. Capital Performance Advisors LLP acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at $41,000. Finally, Northwest Investment Counselors LLC acquired a new position in shares of HCA Healthcare during the third quarter worth $44,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Up 0.5 %

Shares of NYSE HCA opened at $307.29 on Wednesday. The stock has a market capitalization of $77.84 billion, a PE ratio of 13.80, a P/E/G ratio of 1.21 and a beta of 1.64. HCA Healthcare, Inc. has a 52-week low of $276.50 and a 52-week high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a fifty day moving average of $319.34 and a 200-day moving average of $353.44.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were paid a dividend of $0.66 per share. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.86%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Activity

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on HCA shares. Morgan Stanley lowered their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. KeyCorp cut their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Finally, Truist Financial lowered their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $385.27.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.